Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Lymphoma or Leukemia

Completed · Phase 1/Phase 2

Conditions studied: Leukemia, Lymphoma

In brief

RATIONALE: Radiolabeled monoclonal antibodies can locate cancer cells and deliver cancer-killing substances to them without harming normal cells. PURPOSE: Phase I/II trial to study the effectiveness of radiolabeled monoclonal antibody therapy in treating patients who have lymphoma or leukemia that has not responded to previous chemotherapy.

Key facts

Study ID

NCT00004084

Run by

Garden State Cancer Center at the Center for Molecular Medicine and Immunology

People needed

21

Starts

1998-04-01

Last updated by the study team

2011-06-22

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Garden State Cancer Center — Belleville, New Jersey, United States
• University of Pennsylvania Cancer Center — Philadelphia, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.